118 related articles for article (PubMed ID: 35535578)
1. Vaccination in Pediatric Patients with Sickle-Cell Disease: Uptake Report and Mini-Review.
Jarovsky D; Bastos PR; de Matos SF; Almeida FJ; Sáfadi MAP; Hegg ICO; Luporini SM; Berezin EN
J Trop Pediatr; 2022 Apr; 68(3):. PubMed ID: 35535578
[TBL] [Abstract][Full Text] [Related]
2. Adverse Reactions to Pneumococcal Vaccine in Pediatric and Adolescent Patients with Sickle Cell Disease.
Han J; Kemiki O; Hsu LL; Rivers AE
Pharmacotherapy; 2015 Jul; 35(7):696-700. PubMed ID: 26095207
[TBL] [Abstract][Full Text] [Related]
3. Immunization adherence among children with sickle cell disease and sickle cell trait: Results of a population-based study.
Shi JS; Sutaria A; Lakshmanan S; Attell B; Zhou M; Tang A; Eckman J; Snyder A
Pediatr Blood Cancer; 2024 Jul; 71(7):e31042. PubMed ID: 38702922
[TBL] [Abstract][Full Text] [Related]
4. Influenza immunization coverage of children with sickle cell disease.
Peng HK; Dombkowski KJ; Freed GL; Creary SE; Smith D; Reeves SL
Vaccine; 2021 Sep; 39(39):5538-5540. PubMed ID: 34417053
[TBL] [Abstract][Full Text] [Related]
5. Pneumococcal and Meningococcal Vaccination among Michigan Children with Sickle Cell Disease.
Wagner AL; Shrivastwa N; Potter RC; Lyon-Callo SK; Boulton ML
J Pediatr; 2018 May; 196():223-229. PubMed ID: 29555094
[TBL] [Abstract][Full Text] [Related]
6. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
[TBL] [Abstract][Full Text] [Related]
7. Improvement in influenza vaccination rates in a pediatric sickle cell disease clinic.
Sobota AE; Kavanagh PL; Adams WG; McClure E; Farrell D; Sprinz PG
Pediatr Blood Cancer; 2015 Apr; 62(4):654-7. PubMed ID: 25545967
[TBL] [Abstract][Full Text] [Related]
8. Maintenance of a High Influenza Vaccination Rate and Improvement in Health Outcomes in a Pediatric Sickle Cell Disease Clinic.
Lo ZC; Sobota AE
J Pediatr Hematol Oncol; 2022 Jan; 44(1):e46-e50. PubMed ID: 33974583
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and Safety of 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Administered to Children With Sickle Cell Disease Between 8 Weeks and 2 Years of Age: A Phase III, Open, Controlled Study.
Sirima SB; Tiono A; Gansané Z; Siribié M; Zongo A; Ouédraogo A; François N; Strezova A; Dobbelaere K; Borys D
Pediatr Infect Dis J; 2017 May; 36(5):e136-e150. PubMed ID: 28403055
[TBL] [Abstract][Full Text] [Related]
10. Pneumococcal vaccination rates in children with sickle cell disease.
Nero AC; Akuete K; Leasure Reeves S; Dombkowski KJ
J Public Health Manag Pract; 2014; 20(6):587-90. PubMed ID: 24253403
[TBL] [Abstract][Full Text] [Related]
11. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
Menzies R; Turnour C; Chiu C; McIntyre P
Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
[TBL] [Abstract][Full Text] [Related]
12. Incidence of invasive Haemophilus influenzae infections in children with sickle cell disease.
Yee ME; Bakshi N; Graciaa SH; Lane PA; Jerris RC; Wang YF; Yildirim I
Pediatr Blood Cancer; 2019 Jun; 66(6):e27642. PubMed ID: 30724001
[TBL] [Abstract][Full Text] [Related]
13. Estimated mortality rates of individuals with sickle cell disease in Brazil: real-world evidence.
Cançado RD; Costa FF; Lobo C; Migliavaca CB; Falavigna M; Souza Filho HCR; Bueno CT; Silva-Pinto AC
Blood Adv; 2023 Aug; 7(15):3783-3792. PubMed ID: 37104056
[TBL] [Abstract][Full Text] [Related]
14. 13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study.
De Montalembert M; Abboud MR; Fiquet A; Inati A; Lebensburger JD; Kaddah N; Mokhtar G; Piga A; Halasa N; Inusa B; Rees DC; Heath PT; Telfer P; Driscoll C; Al Hajjar S; Tozzi A; Jiang Q; Emini EA; Gruber WC; Gurtman A; Scott DA
Pediatr Blood Cancer; 2015 Aug; 62(8):1427-36. PubMed ID: 25810327
[TBL] [Abstract][Full Text] [Related]
15. Paediatric immunisation and chemoprophylaxis in a Ugandan sickle cell disease clinic.
Chen CJ; Bakeera-Kitaka S; Mupere E; Kasirye P; Munube D; Idro R; Hume H; Pfeffer B; LaRussa P; Green NS
J Paediatr Child Health; 2019 Jul; 55(7):795-801. PubMed ID: 30411430
[TBL] [Abstract][Full Text] [Related]
16. Vaccination Coverage by Age 24 Months Among Children Born in 2017 and 2018 - National Immunization Survey-Child, United States, 2018-2020.
Hill HA; Yankey D; Elam-Evans LD; Singleton JA; Sterrett N
MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(41):1435-1440. PubMed ID: 34648486
[TBL] [Abstract][Full Text] [Related]
17. Alteration of humoral, cellular and cytokine immune response to inactivated influenza vaccine in patients with Sickle Cell Disease.
Nagant C; Barbezange C; Dedeken L; Besse-Hammer T; Thomas I; Mahadeb B; Efira A; Ferster A; Corazza F
PLoS One; 2019; 14(10):e0223991. PubMed ID: 31600331
[TBL] [Abstract][Full Text] [Related]
18. Meningococcal disease epidemiology in Brazil (2005-2018) and impact of MenC vaccination.
Aparecido Nunes A; De Jesus Lopes De Abreu A; Cintra O; A C T Cintra M; Barbosa Coelho E; Nogueira Castro De Barros E
Vaccine; 2021 Jan; 39(3):605-616. PubMed ID: 33358262
[TBL] [Abstract][Full Text] [Related]
19. Impact of meningococcal C conjugate vaccination four years after introduction of routine childhood immunization in Brazil.
Andrade AL; Minamisava R; Tomich LM; Lemos AP; Gorla MC; de Cunto Brandileone MC; Domingues CMS; de Moraes C; Policena G; Bierrenbach AL;
Vaccine; 2017 Apr; 35(16):2025-2033. PubMed ID: 28318769
[TBL] [Abstract][Full Text] [Related]
20. Antibody persistence after serogroup C meningococcal conjugate vaccine in children with sickle cell disease.
Souza AR; Maruyama CM; Sáfadi MA; Lopes MH; Azevedo RS; Findlow H; Bai X; Borrow R; Weckx LY
Vaccine; 2016 Aug; 34(36):4327-34. PubMed ID: 27395566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
